D57.459 Sickle-cell thalassemia beta plus with crisis, unspecified

Name of the Condition

• Sickle-cell thalassemia beta plus with crisis, unspecified

Summary

Sickle-cell thalassemia beta plus with crisis, unspecified is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and beta plus thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of crisis indicates an acute phase with vaso-occlusive episodes, though the specific type of crisis is not further defined.

Causes

Sickle-cell thalassemia beta plus arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a beta plus thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production. The crisis component reflects acute exacerbations of the underlying disorder.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one beta plus thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Complete blood count (CBC) may show anemia and abnormal red blood cell morphology. Hemoglobin electrophoresis or high-performance liquid chromatography (HPLC) identifies abnormal hemoglobin variants. Genetic testing confirms the presence of sickle cell and beta plus thalassemia mutations. Imaging or other tests may be used to assess complications during a crisis.

Treatment Options

Treatment focuses on managing acute crises and preventing complications. Acute pain crises often require hydration, analgesics, and oxygen therapy. Blood transfusions may be used to manage severe anemia or complications. Hydroxyurea can reduce the frequency of crises. Folic acid supplementation supports red blood cell production. Long-term management includes regular monitoring and vaccinations to prevent infections.

Prognosis and Follow-Up

Prognosis varies depending on the severity of crises and complications. Regular follow-up with a hematologist is essential to monitor for organ damage, anemia, and other issues. Preventive care, such as vaccinations and lifestyle modifications, helps reduce complications. Early intervention during crises improves outcomes.

Complications

• Chronic anemia
• Organ damage (e.g., spleen, liver, kidneys)
• Stroke or neurological issues
• Acute chest syndrome
• Splenic sequestration
• Leg ulcers
• Gallstones

Lifestyle & Prevention

• Stay hydrated to reduce crisis risk
• Avoid extreme temperatures
• Manage stress and get adequate rest
• Follow a balanced diet rich in iron and folic acid
• Avoid smoking and excessive alcohol
• Practice good hygiene to prevent infections
• Seek prompt medical care for fever or pain

When to Seek Professional Help

Seek immediate medical attention for:

• Severe pain that is not relieved by usual measures
• Signs of infection (fever, chills)
• Shortness of breath or chest pain
• Sudden weakness or confusion
• Swelling in hands, feet, or abdomen
• Jaundice or dark urine

Tips for Medical Coders

Document the presence of a crisis and specify if additional details (e.g., acute chest syndrome, splenic sequestration) are noted, as these may affect coding. Ensure genetic confirmation of sickle cell and beta plus thalassemia mutations is documented. Use this code when the crisis is present but not further specified.